Language matters. At a February 2016 workshop of leaders committed to expanding patient engagement hosted by FasterCures, just 22 percent felt there was broad agreement on what the term “patient-centered” means or represents. The need to craft a common language emerged as one of the key takeaways from that meeting. The diversity of terms and definitions reflect a nascent field still coming together, but can be confusing when trying to move forward and identify the essential elements of what makes an activity patient-centered. Add to the mix different definitions for the same terms used by regulators, health-care providers and patients themselves and it’s easy to see why a shared taxonomy of terms is a vital step in advancing the science of patient input.
Yet, reaching consensus about the language we use is easier said than done. We all want to be able to use terms and definitions that fit our particular needs and the context in which we operate. To help us move collectively toward a common language that supports the science of patient input, FasterCures reviewed more than 100 public documents and websites and found nearly 200 terms related to patient engagement. In this report we share key findings and recommendations.
In our scan, these four terms turned up most frequently and had the greatest number of unique definitions:
Related Content
-
FasterCures mobilizes for next phase of work to save lives by improving the global medical R&D system, launches health data initiative
WASHINGTON, October 22, 2018 – FasterCures, the Milken Institute center whose mission is to save lives by speeding medical breakthroughs to patients, is announcing new initiatives to engage the private sector, strengthen global partnerships...Read Article -
Metabolic Mind Award Program Update
The Milken Institute in partnership with the Baszucki Brain Research Fund are pleased to announce the individuals selected to receive the 2022 Metabolic Mind Award for their exceptional contributions to the advancement of understanding...Read Article -
The Costs of Chronic Disease in the U.S.
Americans' chronic health problems and diseases not only come at the expense of individuals well-being, they also constitute a massive burden on the U.S. economy. When including the costs of lost economic productivity, the total costs of...Read Report11 11Hugh Waters and Marlon Graf -
Neurotechnology: A Giving Smarter Guide
When most people think about advances in medicine, drug development is the first thing that comes to mind. However, technology and devices are proving to be valuable options for treating intractable illnesses. Technological solutions in the...Read Report11
-
The Impact of Insight: Patient Preferences in Novel Screening Technologies for Cancer
Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product life cycle can create meaningful results...Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product...
11Katie O'Connor and Hadly Clark -
What Kills Americans: Growth of Metabolic Contributors
The most common way to understand the impact of a disease is to track its rates of prevalence and mortality because these metrics are derived from easily collected data. However, prevalence and mortality rates fail to capture whether a...View Research -
Milken Institute Launches COVID-19 Vaccine and Treatment Tracker
Publicly available resource monitors the development of therapies to treat and prevent disease WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development...Read Article -
World Leaders to Descend on Singapore for the 10th Milken Institute Asia Summit, Celebrating a Decade of Progress, Action, and Impact
August 1, 2023 (SINGAPORE) - The annual Milken Institute Asia Summit, taking place from September 13 – 15, will convene regional and global leaders to discuss a wide range of issues and challenges shaping the Asia Pacific region including...Read ArticleImageYeen Chong
Associate Director, Milken Institute InternationalYeen Chee Chong is an associate director for Milken Institute International. Based in Singapore, he oversees and manages strategic communications with a wide range of global and regional media publications and partners. Chong works closely with colleagues in both Asia and the United States on planning and implementing global public relations and social media campaigns. -
Lessons of the Millennium Development Goals
Did the United Nations' ambitious Millennium Development Goals improve the health of people in emerging regions of the world? In this paper, a discussion of the precursors of higher living standards and better health, Milken Institute...Read Report -
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...Read Report11
-
Catalyzing Action for Pharmacist-Provided Food Is Medicine Care
"Catalyzing Action for Pharmacist-Provided Food Is Medicine Care" provides background, insights, and actionable recommendations for pharmacies and key partners, including health-care payers and policymakers, to scale FIM interventions in...Read Report -
Improving Early Detection of Cognitive Impairment and Dementia
DOWNLOAD REPORT The prevalence of mild cognitive impairment (MCI) and dementia is increasing as advancements in medicine, public health, and living standards extend human lifespans. Approximately 12–18 percent of Americans aged 60 and older...Read Report11 11
Diane Ty, Soo Borson, MD, and Katie Partrick, PhD